Journal: Biochimica et biophysica acta. Molecular cell research
Article Title: Proprotein convertase subtilisin/kexin type 9 contributes to cisplatin-induced acute kidney injury by interacting with cyclase-associated protein 1 to promote megalin lysosomal degradation.
doi: 10.1016/j.bbamcr.2025.119984
Figure Lengend Snippet: Fig. 3. PCSK9 inhibitor protects against cisplatin-induced kidney tubule injury. (A) Evolocumab (10 mg/kg) was injected into 8-weeks-old C57BL/6J mice sub cutaneously, 4 h later, cisplatin (25 mg/kg) was intraperitoneally injected, mice were killed 48 h after cisplatin injection. (B) Western blot and statistical analyses of PCSK9 protein expression in mouse renal cortex (n = 4). (C) Western blot and statistical analyses of KIM1 and NGAL protein expression in mouse renal cortex (n = 4). (D) Scr and (E) BUN levels in mouse plasma (n = 4). (F) Urinary albumin/creatinine in mouse urine (n = 4). (G) Representative images of PAS staining in kidney tissue sections and tubular injury score (n = 4, ×200, scale bar = 50 μm; ×400, scale bar = 20 μm). (H) Intrarenal lipid accumulation was evaluated by Oil red O (ORO) staining in kidney tissue sections (n = 4, scale bar = 20 μm). Data are represented as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001.
Article Snippet: The membranes were blocked with 5 % defatted milk for 1 h and then incubated with primary antibodies overnight at 4 ◦C: anti-PCSK9 (1:1000, 27882-1-AP, Proteintech, Wuhan, China), anti- kidney injury molecule 1 (KIM1) (1:1000, bs-2713R, Bioss, China), anti-neutrophil gelatinase-associated lipocalin (NGAL) (1:1000, 26991-1-AP, Proteintech, Wuhan, China), anti-megalin (1:200, sc-515772, Santa Cruz Biotechnology, USA), and anti-CAP1 (1:500, sc-376286, Santa Cruz Biotechnology, USA), anti-β-actin (1:8000, 20536-1-AP, Proteintech, Wuhan, China).
Techniques: Injection, Western Blot, Expressing, Clinical Proteomics, Staining